SCHEMBL29938779

SCHEMBL29938779

N#Cc1ccc(Oc2ccc(C(F)(F)F)cc2)cc1[N+](=O)[O-]

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 1/20 0.49
AR P10275 4/20 0.47
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
TTR P02766 1/20 0.42
PPOX P50336 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MAPT P10636 4/20 0.40
MERTK Q12866 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
KDM4E B2RXH2 3/20 0.40
HPGD P15428 3/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP2C9 P11712 1/20 0.40
MAPK1 P28482 1/20 0.40
ESRRA P11474 1/20 0.39
PLA2G7 Q13093 1/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24750303 1.00 VCAM1 (0.49) VCAM1ARMEN1KMT2ATTR
SCHEMBL29938776 0.89 MEN1 (0.45) VCAM1ARMEN1KMT2ATTR
SCHEMBL11481976 0.87 VCAM1 (0.62) VCAM1ARTDP1MAPTMERTK
SCHEMBL463657 0.84 VCAM1 (0.58) VCAM1MEN1KMT2ATDP1MAPT
SCHEMBL31672177 0.84 VCAM1 (0.58) VCAM1MEN1KMT2ATDP1MAPT
SCHEMBL31672176 0.84 VCAM1 (0.58) VCAM1MEN1KMT2ATDP1MAPT
SCHEMBL11714812 0.83 VCAM1 (0.54) VCAM1ARMEN1KMT2ATTR
SCHEMBL10454825 0.83 ALDH1A1 (0.50) MEN1KMT2ATTRPPOXTDP1
SCHEMBL10854566 0.82 MEN1 (0.52) ARMEN1KMT2ATTRPPOX
SCHEMBL7689338 0.80 VCAM1 (0.54) VCAM1MEN1KMT2ATDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4631573-A2 TEAD INHIBITORS Orion Corporation (FI) 2025-10-15 EP disclosed
EP-4323338-B1 TEAD INHIBITORS ORION CORP (FI) 2025-10-08 EP disclosed
US-20240246908-A1 TEAD INHIBITORS ORION CORPORATION (FI) 2024-07-25 US disclosed
EP-4323338-A1 TEAD INHIBITORS Orion Corporation (FI) 2024-02-21 EP disclosed
CN-117500786-A TEAD inhibitors 奥赖恩公司 2024-02-02 CN disclosed
WO-2022219246-A1 TEAD INHIBITORS ORION CORPORATION (FI) 2022-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246908-A1 TEAD INHIBITORS TEAD3, TEAD1, TEAD2 VCAM1 3453/4885AR 1868/4885MEN1 2064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.